Next-generation sequencing (NGS) technologies have progressive advantages in terms of cost-effectiveness, unprecedented sequencing speed, high resolution and accuracy in genomic analyses, thus are playing an increasing important role in fields of oncology and immunology. Through our cutting-edge SuPrecision™ platform, Creative Biolabs offers high-quality NGS-based services, such as whole genome sequencing (WGS), Applications of WES in cancer research www.creative-biolabs.com/suprecision/application.htm